ResearcherNational University of SingaporeActive in the last 2 years

Zheng Zhong

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1614-7798; OpenAlex author ID A5072697627. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2022: 1 paper · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 2

Oncogenic KRAS/ERK/JUNB signaling suppresses differentiation regulator GATA6 in pancreatic cancer. Co-author DOI 10.1172/jci191370 ↗
A p300/GATA6 axis determines differentiation and Wnt dependency in pancreatic cancer models. Co-author DOI 10.1172/jci156305 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

David M. Virshup · 2 shared papers, 2022–2026 · strength 0.49
- Paper Oncogenic KRAS/ERK/JUNB signaling suppresses differentiation regulator GATA6 in pancreatic cancer. DOI 10.1172/jci191370 ↗
- Paper A p300/GATA6 axis determines differentiation and Wnt dependency in pancreatic cancer models. DOI 10.1172/jci156305 ↗
Clint A. Stalnecker · 1 shared paper, 2026 · strength 0.29
- Paper Oncogenic KRAS/ERK/JUNB signaling suppresses differentiation regulator GATA6 in pancreatic cancer. DOI 10.1172/jci191370 ↗
Channing J. Der · 1 shared paper, 2026 · strength 0.29
- Paper Oncogenic KRAS/ERK/JUNB signaling suppresses differentiation regulator GATA6 in pancreatic cancer. DOI 10.1172/jci191370 ↗
Babita Madan · 1 shared paper, 2022 · strength 0.20
- Paper A p300/GATA6 axis determines differentiation and Wnt dependency in pancreatic cancer models. DOI 10.1172/jci156305 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.